However, the transcripts of TAT, HPD, HGD, GSTZ1 and FAH significantly reduced in the HCC stage 2 and stage 3 compared to normal liver (Fig 2B, p < 0.05). This evidence concerns the gene TAT and hepatocellular carcinoma.